Biodexa Pharmaceuticals Plc (NASDAQ:BDRX – Get Free Report) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 322,000 shares, a decrease of 84.4% from the April 30th total of 2,060,000 shares. Based on an average daily volume of 4,960,000 shares, […]
Biodexa announced the exercise of previously issued warrants and an agreement between the company and several investors to exercise certain existing Series E and Series F warrants to purchase up to approximately 4.36 million of the company's American Depositary Shares (ADS).